VANGUARD GROUP INC - NEUROONE MED TECHNOLOGIES CO ownership

NEUROONE MED TECHNOLOGIES CO's ticker is NMTC and the CUSIP is 64130M209. A total of 12 filers reported holding NEUROONE MED TECHNOLOGIES CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of NEUROONE MED TECHNOLOGIES CO
ValueSharesWeighting
Q3 2023$391,314
-25.9%
439,481
-0.2%
0.00%
Q2 2023$528,304
-26.2%
440,253
-1.0%
0.00%
Q1 2023$716,226
+565.6%
444,861
+396.1%
0.00%
Q4 2022$107,598
-23.7%
89,665
+8.1%
0.00%
Q3 2022$141,000
-28.4%
82,918
-65.4%
0.00%
Q2 2022$197,000
-25.4%
239,3910.0%0.00%
Q1 2022$264,000
-37.3%
239,391
+10.2%
0.00%
Q4 2021$421,000217,2320.00%
Other shareholders
NEUROONE MED TECHNOLOGIES CO shareholders Q1 2022
NameSharesValueWeighting ↓
Intersect Capital LLC 50,000$198,0000.03%
PREMIER ASSET MANAGEMENT LLC 50,000$197,0000.03%
Tower Research Capital LLC (TRC) 4,907$20,0000.00%
HRT FINANCIAL LP 39,175$154,0000.00%
WELLS FARGO & COMPANY/MN 54$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 106,151$419,0000.00%
Cutler Group LLC / CA 500$1,0000.00%
Cutler Group LLC / CA 200$00.00%
Cutler Group LLC / CA 400$00.00%
View complete list of NEUROONE MED TECHNOLOGIES CO shareholders